Milne David Bruce's Form 4 filing
Asensus Surgical, Inc. (ASXC) · filed Mar 8, 2022
- Accession no.
- 0001209191-22-016901
- Filed
- Mar 8, 2022
- Trade date
- Mar 4-7, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 7 non-derivative transactions. Open-market purchases total $235.2K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Milne David BruceCIK 0001585207 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 4, 2022 | Common Stock | PPurchaseAcquired | +50,000 | $0.64F1 | +$32,000 | 294,884 | Direct | |
| Mar 4, 2022 | Common Stock | PPurchaseAcquired | +50,000 | $0.64F2 | +$32,000 | 344,884 | Direct | |
| Mar 4, 2022 | Common Stock | PPurchaseAcquired | +50,000 | $0.63F3 | +$31,500 | 394,884 | Direct | |
| Mar 7, 2022 | Common Stock | PPurchaseAcquired | +50,000 | $0.61F4 | +$30,500 | 444,884 | Direct | |
| Mar 7, 2022 | Common Stock | PPurchaseAcquired | +100,000 | $0.62F5 | +$62,000 | 544,884 | Direct | |
| Mar 7, 2022 | Common Stock | PPurchaseAcquired | +5,768 | $0.62F6 | +$3,576.16 | 550,652 | Direct | |
| Mar 7, 2022 | Common Stock | PPurchaseAcquired | +69,232 | $0.63F7 | +$43,616.16 | 619,884 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6305 to $0.64 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F2
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6385 to $0.6485 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6325 to $0.64 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F4
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6051 to $0.6136 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F5
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.61 to $0.6161 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F6
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6161 to $0.62 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F7
The purchase price reported here is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.6232 to $0.63 inclusive. The reporting person undertakes to provide to Asensus Surgical, Inc., any security holder of Asensus Surgical, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4.
Referenced by the price of 1 transaction in Table I.